carcinoembryonic antigen peptide 1-6D
Term · Oncology and biomedicine · MLC-T-ONC-012303
A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.
| Identifier | MLC-T-ONC-012303 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | CEA PEP 1-6D |
| Synonyms | CEA:571-579 (576D); modified CEA peptide; mCEA peptide |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012303",
"term": "carcinoembryonic antigen peptide 1-6D",
"field": "Oncology and biomedicine",
"definition": "A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.",
"abbreviation": "CEA PEP 1-6D",
"synonyms": [
"CEA:571-579 (576D)",
"modified CEA peptide",
"mCEA peptide"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carcinoembryonic-antigen-peptide-1-6d/"
}
Record 4,219 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.